| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.0085 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |